期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Dkk-3在原发性肝细胞癌的表达及其临床意义 被引量：4

Expression and clinical significance of Dkk-3 in primary hepatocellular carcinoma
暂未订购
导出
摘要 目的研究Dkk-3在原发性肝细胞癌的表达及其临床意义。方法采用免疫组织化学(SP)法检测该院普外科手术切除的80例原发性肝细胞癌肿瘤及癌旁正常组织Dkk-3表达,比较原发性肝细胞癌不同临床病理因素中Dkk-3表达的差异,分析Dkk-3表达与临床病理因素的相关性。结果癌旁正常肝组织Dkk-3表达评分[(10.1±2.6)分]显著高于肝癌组织[4.8±1.1)分],差异有统计学意义(P<0.01)。原发性肝细胞癌Dkk-3蛋白质表达在性别和年龄中的差异无统计学意义(P>0.05),肿瘤最大径越大、临床分期越晚及有转移时原发性肝细胞癌Dkk-3蛋白质低表达越低(P<0.05)。原发性肝细胞癌Dkk-3蛋白质表达与肿瘤最大径、临床分期及有转移呈负相关关系(P<0.05)。结论 Dkk-3在原发性肝细胞癌中呈低表达状态,可作为原发性肝细胞癌病情及预后评估的标志物。 Objective To study the expression of Dkk-3in primary hepatocellular carcinoma （ PHC ） and its dinical significance. Methods Immunohistochemistry was applied to detect the Dkk-3expression levels in 80cases with PHC.The correlation between expression levels of Dkk-3and clinicopathologic factors was analyzed.Results The expression levels of Dkk-3in PHC tissues were higher than those in adjacent normal tissues.The expression levels of Dkk-3in PHC were negatively correlated with tumor size , clinical staging and metastasis.Conclusion The expression levels of Dkk-3in PHC might be low , which could act as a biomarker for e- valuating condition and prognosis.
作者 肖述兵 彭碧华 万金龙 郑祖祥
机构地区 湖北仙桃市第一人民医院病理科 湖北仙桃市第一人民医院普外科
出处 《国际检验医学杂志》 CAS 2012年第16期1952-1953,共2页 International Journal of Laboratory Medicine
关键词 癌 肝细胞 Dkk-3 基因表达 carcinoma hepatocellular Dkk-3 gene expression
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献32

  • 1Dumez A, Verslype C, Nevens F, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 ex pression in hepatocellular carcinoma. A possible progenitor cell origin[J]. Histopathology, 2006, 49(2): 138.
  • 2Suzuki T, Yano H, Nakashima Y, et al. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-eatenin in the dedifferentiation proeess[J]. J Gastroenterol Hepatol, 2002, 17(9) : 994.
  • 3Eidler H B, Utsuyarna M, Nagaoka S, et al. Expression level of Wnt signaling components possibly influences the biological behavior of coloreetal cancer in different age groups [J]. Exp Mol Pathol, 2004, 76(3) : 224.
  • 4Lustig B, Behrens J. The Wnt signaling pathway and it sroleintum or development [J]. J Cancer Res Clin Oncol, 2003, 129(4): 199.
  • 5Shinji U, Hiroaki S, Hideki E, et al. Combination analysis of hypermethylated Wnt-Antagonist family gene as a novel epigenetic biomarker panel for bladder cancer detection [J]. Clin Cancer Res, 2006, 12(7) : 2109.
  • 6Kazuyasu K, Mamoru O, Toshiya T, et al. Reduced expression of the REIC/DKK-3 gene by promoter-hypermethylation in human tumor cells [J]. Gene, 2002, 282(1) : 151.
  • 7Edamoto Y, Hara A, Biernat W, et al. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis [J]. Int J Cancer, 2003, 106(3) : 334.
  • 8Loeppen S, Koehle C, Buchrnann A, et al. A beta-catenin dependent pathway regulates expression of eytochrome P450 isoforms in mouse liver tumors [ J ]. Carcinogenesis, 2005, 26( 1 ) : 239.
  • 9Julien M, Biao He, Liang You, et al. Wnt inhibitory factor- 1 is silenced by pZXSromoter hypermethylation in human lung cancer[J]. Cancer Res, 2004, 64(14): 4717.
  • 10Sonny B,atra, Yihui Shi, Kristopher M, et al. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylatlon in malignant pleural mesothelioma [J]. BBRC, 2006, 342(4): 1228.

共引文献41

同被引文献33

  • 1Sung JJ,Lau JY,Goh KL,et al.Increasing incidence of colorectal cancer in Asia:implications for screening[J].Lancet Oncol,2005,6(11):871-876.
  • 2Espey DK,Wu XC,Swan J,et al.Annual report to the nation on the status of cancer,1975-2004,featuring cancer in American Indians and Alaska Native s[J].Cancer,2007,110(10):2119-2152.
  • 3Rim SH,Seeff L,Ahmed F,et al.Colorectal cancer incidence in the United States,1999-2004:an updated analysis of data from the National Program of Cancer Registries and the Surveillance,Epidemiology,and End Results Program[J].Cancer,2009,115(9):1967-1976.
  • 4Krupnik VE,Sharp JD,Jiang C,et al.Functional and structural diversity of the human Dickkopf gene family[J].Gene,1999,238(2):301-313.
  • 5Zenzmaier C,Untergasser G,Hermann M,et al.Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue[J].Prostate,2008,68(5):540-547.
  • 6Sato H,Suzuki H,Toyota M,et al.Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors[J].Carcinogenesis,2007,28(12):2459-2466.
  • 7Baffa R,Negrini M,Mandes B,et al.Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach[J].Cancer Res,1996,56(2):268-272.
  • 8Krysko DV,Vanden Berghe T,D'Herde K,et al.Apoptosis and necrosis:detection,discrimination and phagocytosis[J].Methods,2008,44(3):205-221.
  • 9Krysko DV,D'Herde K,Vandenabeele P.Clearance of apoptotic and necrotic cells and its immunological consequences[J].Apoptosis,2006,11(10):1709-1726.
  • 10Karna P,Sharp SM,Yates C,et al.EM011 activates a survivin-dependent apoptotic program in human nonsmall cell lung cancer cells[J].Mol Cancer,2009,8:93.

引证文献4

二级引证文献2

国际检验医学杂志
2012年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部